The global livestock and aquaculture sectors have maintained steady growth in recent years, which has directly boosted the market demand for veterinary pharmaceuticals, biological vaccines and related animal health products across the world. As large-scale, intensive and standardized farming modes gradually replace traditional breeding methods, breeders and agricultural operators around the world have raised higher standards for the safety, efficacy and stability of animal medicines. Products covering poultry vaccines, livestock vaccines, antibacterial injections, soluble powders, antiparasitic agents and environmental disinfectants are all witnessing sustained growth in export volume.
Regulatory policies vary from region to region, yet compliance has universally become the top priority for the whole industry. Major overseas markets including the Middle East, South Asia, Southeast Asia and European countries have formulated complete sets of access rules for imported veterinary products. Strict requirements are imposed on production environment, quality management system, product test reports and technical dossiers. Enterprises engaged in foreign trade of veterinary products have to keep pace with updated regulations, optimize production procedures in line with GMP guidelines, and strengthen full-process quality control from raw material procurement to finished product delivery.
Industry insiders believe that the upward trend of veterinary product foreign trade will continue in the long run. Markets in emerging economies still have huge potential to be tapped, while mature markets focus more on high-end products and innovative biological vaccines. Only those who attach importance to product quality, keep learning international regulatory rules and build stable supply chains can seize more development opportunities in the fiercely competitive global market.